Article
Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost.
Antimicrobial agents and chemotherapy - 1 May 2012
Couce Alejandro, Briales Alejandra, Rodríguez-Rojas Alexandro, Costas Coloma, Pascual Alvaro, Blázquez Jesús
Abstract excerpt
To determine whether the overexpression of chromosomal genes can confer fosfomycin resistance, genomewide screening of a complete set of 5,272 plasmid-expressed open reading frames of Escherichia coli (ASKA collection) was performed. Major results are that (i) no clinical level of resistance is achieved by overexpressing chromosomal genes, except murA; (ii) this level is reached at a low fitness cost; and (iii)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
